Nicollet Investment Management’s ResMed RMD Stock Holding History

Nicollet Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.56M	Sell	24,783 -894	-3%	-$223K	1.91%	15
2025 Q4	$6.18M	Buy	25,677 +92	+0.4%	+$23.5K	1.96%	16
2025 Q3	$7M	Sell	25,585 -892	-3%	-$244K	2.28%	13
2025 Q2	$6.83M	Sell	26,477 -1,432	-5%	-$342K	2.29%	13
2025 Q1	$6.25M	Buy	27,909 +27	+0.1%	+$6.3K	2.2%	13
2024 Q4	$6.38M	Sell	27,882 -466	-2%	-$112K	2.19%	15
2024 Q3	$6.92M	Buy	28,348 +54	+0.2%	+$12.1K	2.39%	11
2024 Q2	$5.42M	Sell	28,294 -430	-1%	-$87.2K	2.02%	16
2024 Q1	$5.69M	Buy	+28,724	New	+$5.26M	2.1%	14

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nicollet Investment Management's RMD Position: Q1 2026 in Review

Nicollet Investment Management reduced its ResMed (RMD) stake by 3.5% in Q1 2026, selling an estimated $223K and leaving 24,783 shares worth $5.56M. The position accounts for 1.91% of the portfolio, ranked #15.

Nicollet Investment Management first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $7M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Nicollet Investment Management held 24,783 shares of ResMed worth $5.56M as of Q1 2026.
Nicollet Investment Management sold 894 ResMed shares in Q1 2026, an estimated $223K.
ResMed made up 1.91% of Nicollet Investment Management's portfolio in Q1 2026, its #15 holding.
Nicollet Investment Management first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
Nicollet Investment Management's ResMed position peaked at $7M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Nicollet Investment Management's 13F filing for Q1 2026, filed 13 May 2026.